1. Home
  2. TMDX vs REZI Comparison

TMDX vs REZI Comparison

Compare TMDX & REZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • REZI
  • Stock Information
  • Founded
  • TMDX 1998
  • REZI 2018
  • Country
  • TMDX United States
  • REZI United States
  • Employees
  • TMDX N/A
  • REZI N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • REZI Wholesale Distributors
  • Sector
  • TMDX Health Care
  • REZI Industrials
  • Exchange
  • TMDX Nasdaq
  • REZI Nasdaq
  • Market Cap
  • TMDX 2.3B
  • REZI 2.7B
  • IPO Year
  • TMDX 2019
  • REZI N/A
  • Fundamental
  • Price
  • TMDX $88.24
  • REZI $15.77
  • Analyst Decision
  • TMDX Buy
  • REZI
  • Analyst Count
  • TMDX 10
  • REZI 0
  • Target Price
  • TMDX $118.44
  • REZI N/A
  • AVG Volume (30 Days)
  • TMDX 1.1M
  • REZI 1.4M
  • Earning Date
  • TMDX 04-29-2025
  • REZI 05-01-2025
  • Dividend Yield
  • TMDX N/A
  • REZI N/A
  • EPS Growth
  • TMDX N/A
  • REZI N/A
  • EPS
  • TMDX 1.01
  • REZI 0.61
  • Revenue
  • TMDX $441,540,000.00
  • REZI $6,761,000,000.00
  • Revenue This Year
  • TMDX $25.33
  • REZI $9.42
  • Revenue Next Year
  • TMDX $20.53
  • REZI $2.22
  • P/E Ratio
  • TMDX $87.37
  • REZI $25.85
  • Revenue Growth
  • TMDX 82.74
  • REZI 8.31
  • 52 Week Low
  • TMDX $55.00
  • REZI $14.18
  • 52 Week High
  • TMDX $177.37
  • REZI $28.28
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 70.61
  • REZI 40.58
  • Support Level
  • TMDX $82.62
  • REZI $14.97
  • Resistance Level
  • TMDX $88.48
  • REZI $15.90
  • Average True Range (ATR)
  • TMDX 5.48
  • REZI 0.98
  • MACD
  • TMDX 1.98
  • REZI -0.01
  • Stochastic Oscillator
  • TMDX 99.09
  • REZI 35.49

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About REZI Resideo Technologies Inc.

Resideo Technologies Inc is a manufacturer and developer of technology-driven products and components that provide critical comfort, energy management, and safety and security solutions. The company has two reportable segments; Products and Solutions segment offers temperature and humidity control, energy products and solutions, water and air solutions, smoke and carbon monoxide detection home safety products, security panels, sensors, peripherals, wire and cable, communications devices, video cameras, other home-related lifestyle convenience solutions; and ADI Global Distribution segment includes wholesale distributor of low-voltage security products including access control, fire detection, security, and video products. It derives majority of its revenue from the United States.

Share on Social Networks: